Spota | Accession Numberb | Protein Description | Mr(KDa)/ pI | Score | Coverage (%)d | Normalized spot volume (vol%)e | p | Ratio (infected/mock-infected) | Protein functions | Other viruses found inf | |
---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  | Mock-infected | IBV-infected |  |  |  |  |
Cytoskeletal and calcium ion-binding proteins | |||||||||||
1 | gi|55584150 | Myosin light chain 3, skeletal muscle isoform [Gallus gallus] | 16.7/4.52 | 81c | 38 | 0.1007 ± 0.0245 | 0.0452 ± 0.0118 | 0.024 | 0.45 | Motor activity. Calcium ion binding. | IAV, RSV, CVB3 |
2 | gi|212347 | Myosin light chain 1, skeletal muscle isoform [Gallus gallus] | 19.5/4.96 | 192 | 53 | 0.6040 ± 0.0519 | 0.3576 ± 0.0656 | 0.007 | 0.59 | Motor activity. Calcium ion binding. |  |
16 | gi|50403707 | myosin light chain type 2 (LC2f) [Gallus gallus] | 18.9/4.77 | 220 | 33 | 0.4716 ± 0.0545 | 0.2784 ± 0.0257 | 0.005 | 0.59 | Motor activity. Calcium ion binding. | VHSV |
18 | gi|46195459 | annexin A1 [Gallus gallus] | 38.5/7.05 | 142c | 39 | 0.1277 ± 0.0106 | 0.0596 ± 0.0118 | 0.002 | 0.47 | Calcium/phospholipid-binding protein. Promotes membrane fusion. Involved in exocytosis. Regulates phospholipase A2 activity. Inflammation response | CSFV, PRRSV, HBV, RSV, VHSV, WNV |
Carbohydrate and lipid metabolic proteins | |||||||||||
3 | gi|20178282 | Extracellular fatty acid-binding protein [Gallus gallus] | 20.1/5.56 | 361 | 46 | 0.0495 ± 0.0094 | 0.1058 ± 0.0221 | 0.015 | 2.14 | Fatty acid binding and transporting. Inflammatory response. |  |
17 | gi|45382875 | Creatine kinase M chain [Gallus gallus] | 43.3/6.5 | 287 | 50 | 0.5632 ± 0.0122 | 0.2546 ± 0.0488 | < 0.001 | 0.45 | Nucleotide binding. Catalytic activity. Creatine kinase activity | HBV, VHSV |
Stress response protein | |||||||||||
15 | gi|45384222 | Heat shock 27 kDa protein [Gallus gallus] | 21.7/5.77 | 166 | 61 | 0.2906 ± 0.0637 | 0.1531 ± 0.0432 | 0.036 | 0.53 | Response to stress. Anti-apoptosis | CSFV, PRRSV, PCV2, ASFV, AIV, MDV, IBDV, REOV, 1AV, CVB3 |
Protein and nucleotide processing | |||||||||||
5 | gi|122692295 | ubiquitin carboxyl-terminal esterase L1 [Gallus gallus] | 25.1/5.74 | 142 | 31 | 0.0563 ± 0.0019 | 0.0980 ± 0.0071 | 0.001 | 1.74 | Ubiquitin binding, Protein deubiquitination | DHBV, IBDV |
6 | gi|45382983 | replication factor C (activator 1) 2, 40 kDa [Gallus gallus] | 40.1/5.68 | 87c | 45 | 0.0542 ± 0.0128 | 0.1931 ± 0.0297 | 0.002 | 3.56 | Nucleotide binding. ATP binding |  |
10 | gi|52138673 | chaperonin containing TCP1, subunit 8 (theta) [Gallus gallus] | 59.5/5.35 | 300 | 37 | 0.0403 ± 0.0031 | 0.0760 ± 0.0047 | 0.001 | 1.89 | Protein binding. Nucleotide binding | PRRSV, EV71, HPV8, IAV |
11 | gi|52138673 | chaperonin containing TCP1, subunit 8 (theta) [Gallus gallus] | 59.5/5.35 | 356 | 47 | 0.0559 ± 0.0021 | 0.1228 ± 0.0375 | 0.037 | 2.20 | Protein binding. Nucleotide binding | PRRSV, EV71, HPV8, IAV |
4 | gi|150247116 | Putative uncharacterized protein TRIM27.2 (Tripartite motif-containing) [Gallus gallus] | 27.2/5.25 | 289c | 46 | 0.0792 ± 0.0116 | 0.2098 ± 0.0196 | 0.001 | 2.65 | Protein binding. Metal ion binding |  |
9 | gi|45383758 | cholinergic receptor, nicotinic, alpha 7 precursor [Gallus gallus] | 56.9/5.47 | 159c | 29 | 0.0323 ± 0.0055 | 0.0723 ± 0.0182 | 0.022 | 2.24 | Acetylcholine receptor activity. Activation of MAPK activity. Cellular calcium ion homeostasis |  |
7 | gi|71896049 | cholinergic receptor, nicotinic, gamma polypeptide precursor [Gallus gallus] | 59.6/5.53 | 142c | 26 | 0.0701 ± 0.0132 | 0.1207 ± 0.0039 | 0.003 | 1.72 | Nicotinic acetylcholine-activated cation-selective channel activity. Ion channel activity |  |
8-1 | gi|45382569 | ARP2 actin-related protein 2 homolog [Gallus gallus] | 45.0/6.3 | 157c | 51 | 0.0747 ± 0.0027 | 0.1336 ± 0.0187 | 0.006 | 1.79 | ATP binding. Actin binding. Protein binding |  |
13 | gi|71895337 | ovoinhibitor precursor [Gallus gallus] | 54.4/6.16 | 128c | 39 | 0.0334 ± 0.0139 | 0.1046 ± 0.0364 | 0.034 | 3.13 | Serine-type endopeptidase inhibitor activity. Peptidase inhibitor activity. |  |
14 | gi|71895337 | ovoinhibitor precursor [Gallus gallus] | 54.4/6.16 | 291 | 40 | 0.0545 ± 0.0228 | 0.1074 ± 0.0119 | 0.029 | 1.97 | Serine-type endopeptidase inhibitor activity. Peptidase inhibitor activity. |  |
Signal transduction | |||||||||||
12 | gi|124249432 | Rho GDP dissociation inhibitor (GDI) alpha [Gallus gallus] | 23.3/5.22 | 264 | 60 | 0.1091 ± 0.0127 | 0.0619 ± 0.0131 | 0.011 | 0.57 | Rho GDP-dissociation inhibitor activity. Signal transduction | CSFV, RSV, WSSV, YHV, IBDV |
Metal ion binding | |||||||||||
8-2 | gi|17942831 | Chain A, Ovotransferrin, C-Terminal Lobe, Apo Form | 39.4/6.31 | 93c | 49 | 0.0747 ± 0.0027 | 0.1336 ± 0.0187 | 0.006 | 1.79 | Metal ion binding. Iron ion transport |  |